University Hospitals Birmingham NHS Foundation Trust

Search results for ""

Status Drug name NICE TAs Comments
Status: Red Lignocaine
Status: Amber Lignocaine 5% medicated plasters (30 plasters)

RICaD
Status: Amber Linaclotide

For moderate to severe IBS-Constipation. For patients who have not responded adequately to or cannot tolerate all other suitable treatment options BUT BEFORE other agents with higher costs.
Status: Green Linagliptin tablets
Status: Red Liothyronine injection
Status: Amber Liothyronine tablets

ESCA in development
Status: Green Liquid paraffin (VitA-POS®)

Second line
Status: Green Liquid paraffin (Xailin® night)
Status: Green Liquid paraffin and white soft paraffin 50:50 ointment
Status: Red Liraglutide (Saxenda®) (GLP1s should all be prescribed by brand name)

The use of Liraglutide for this indication is restricted to prescribing in secondary care by a specialist multidisciplinary Tier 3 weight management service with a commercial agreement in place.

Prescribe by brand (Saxenda®) to avoid patients inadvertently receiving a different product licensed for type 2 diabetes.
Building healthier lives
Back to top